TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotec Pharmacon ASA
Closing information (x1000 NOK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 84,395 | 72,817 | 72,758 |
Financial expenses | 811 | 0 | 695 |
Earnings before taxes | -5,926 | -13,828 | -24,803 |
Total assets | 77,608 | 68,015 | 61,684 |
Current assets | 58,590 | 55,867 | 49,967 |
Current liabilities | 18,368 | 14,117 | 16,870 |
Equity capital | 46,476 | 53,898 | 44,813 |
- share capital | 48,335 | 48,335 | 43,945 |
Employees (average) | 38 | 43 | 44 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 59.9% | 79.2% | 72.6% |
Turnover per employee | 2,221 | 1,693 | 1,654 |
Profit as a percentage of turnover | -7.0% | -19.0% | -34.1% |
Return on assets (ROA) | -6.6% | -20.3% | -39.1% |
Current ratio | 319.0% | 395.7% | 296.2% |
Return on equity (ROE) | -12.8% | -25.7% | -55.3% |
Change turnover | 11,578 | 59 | -5,848 |
Change turnover % | 16% | 0% | -7% |
Chg. No. of employees | -5 | -1 | -2 |
Chg. No. of employees % | -12% | -2% | -4% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.